Forearm surgery. Unspecified acquired deformity of forearm
Conditions
Interventions
Intervention 1: Intervention group 1: 10 mg/kg magnesium sulfate (50%) manufactured by Shahid Ghazi Tabriz Pharmaceutical Company will be used. Intervention 2: Intervention group 2: 2 mg granisetron (
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 65 Years
Inclusion criteria
Inclusion criteria: Both sexes Candidate for forearm surgery ASA class one and two No Raynaud's disease No sickle cell anemia No history of allergy to the drugs used in the study No cyanosis patient No use of narcotics and psychotropic drugs No contraindications to intravenous anesthesia No more than one fracture in the body or surgery No pregnancy No chronic pain syndrome No neurological disorders in the hand
Exclusion criteria
Exclusion criteria: If the duration of the surgery exceeds 90 minutes, these patients will be excluded from the study due to possible complications after opening the tourniquet that has been inflated for more than 90 minutes (due to the limitation on the time the tourniquet remains inflated). For any reason, intravenous local anesthesia wears off during the procedure (becomes ineffective). If the duration of the operation is less than 30 minutes, these patients will be excluded from the study due to possible complications after opening the tourniquet that has been in place for less than 30 minutes (due to the possibility of complications in opening the tourniquet earlier than 30 minutes).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: After the tourniquet is inflated, and at times 15, 30, and 45, and every 15 minutes until the end of the surgery. Method of measurement: Visual analog scale of pain. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Shirin Pazuki
Arak University of Medical Sciences
Outcome results
None listed